Philips Signs Agreement to Create Taiwan's First Fully Digitalized Pathology Department

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to transform its pathology tissue examination to digital diagnostics. By allowing tissue samples to be remotely viewed within a virtual pathology network across hospital locations, the Philips IntelliSite Pathology Solution will help TPVGH to establish Taiwan's first fully digitalized pathology department, with the aim of enhancing patient safety and improving the quality of diagnoses, thereby leading to better patient outcomes.

Cancer is the leading cause of death in Taiwan. Pathology plays a critical role in the detection and diagnosis of a wide variety of diseases, including cancer. Tissue samples (biopsies) are examined to determine if tissue cells are malignant and consequently to guide treatment decisions. Speedy diagnosis and effective personalized treatment have a significant impact on patients and their families.

Pathological review of patient tissue has historically been done using a microscope. Using the Philips IntelliSite Pathology Solution with the Ultra-Fast Scanner (UFS), TPVGH will now be able to digitize tissue samples so that pathologists can review, interpret, analyze, and share digital images. The Image Management System (IMS) that is part of the Philips IntelliSite Pathology Solution allows them to instantly consult colleagues or conveniently present images during multi-disciplinary team meetings, without the need to physically transport pathology slides or tissue samples.

"Philips Taiwan continues to help Taiwan in realizing intelligent and advanced healthcare solutions," said Richard Hu, General Manager of Philips Taiwan. "Digitalizing pathology so that tissue samples can be viewed remotely, wherever they are needed, will not only enhance laboratory efficiency and quality but also improve patient safety."

In addition to clinical use, the digital images will be stored in image repositories and used to teach pathology students, or used for medical research, including cancer research.

Philips IntelliSite Pathology Solution is designed for in-vitro diagnostic purposes, helping pathologists to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue samples. It has market access clearance in over fifty countries, including recent market clearance in Taiwan.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

Most Popular Now

App Determines COVID-19 Disease Severity…

A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases. Created by researchers at NYU College of Dentistry, the...

NHS Trust Revolutionises Access to Menta…

North Staffordshire Combined Healthcare NHS Trust has selected the DXC Open Health Connect platform from DXC Technology (NYSE: DXC) and is creating a blueprint that could dramatically reduce mental health...

FDA Permits Marketing of First Game-Base…

The U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD). The prescription-only...

HealthTunes Launches iOS App to Deliver …

HealthTunes has announceed the launch of the iOS App specifically created to help alleviate the mental health suffering of frontline healthcare workers. After months of fighting the pandemic, many frontline...

Bluetooth Technology, the Best Ally to D…

"Tracers have been and are essential to manage the pandemic. Today, the tracing is done by hand and this work is slow and inaccurate. However, as we have seen, technology...

Artificial Intelligence can Improve How …

According to a recent report by Johns Hopkins Medicine researchers, artificial intelligence (AI) should be used to expand the role of chest X-ray imaging - using computed tomography, or CT...

Philips Announces Collaboration with Ame…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has once again joined forces with the American Telemedicine Association (ATA) to help further the...

Successful Debut for DMEA sparks

16 - 18 June 2020, Berlin, Germany. DMEA sparks opened, featuring a wide range of topics. Federal Minister of Health Jens Spahn kicked off events. In his interview he focused on...

Digital Mental Health support to be Prov…

SilverCloud, the leading digital therapeutics provider, has partnered with mental health charity Northpoint Wellbeing to co-develop a new digital therapy programme to alleviate anxiety in young people. Coming at a...

Siemens Healthineers Offers Flexible Tel…

With its teamplay myCare Companion software, the company is bringing a new and flexible telemedicine solution to the market that enables remote care for patients with chronic diseases. The teamplay...

Andrea Fiumicelli Appointed as a CEO of …

Dedalus Group, leader in Europe and one of the world's leading players in clinical and healthcare information systems supporting clinical professionals and healthcare facilities thanks to a wide portfolio of...

Computer Modelling Predicts where Vaccin…

Researchers have developed a model that can estimate regional disease burden and the impact of vaccination, even in the absence of robust surveillance data, a study in eLife reveals. The report...